Efforts underway to arrange for Muharram elephant as Forest Department raises concerns
According to sources, the Telangana State Waqf Board (TGSWB), along with officials from other departments, have been exploring possibilities for arranging the elephant, as the procession is likely to take place on July 6 or July 7, depending on the sighting of the moon.
Correspondence regarding the arrangement usually takes place between the H.E.H. The Nizam Awqaf Committee, the Nizam's Religious Trust, and the government. However, it is the Telangana State Waqf Board that bears the costs of transporting and handling the elephant, along with other related expenses. These expenses amount to approximately ₹5 lakh, with an advance paid prior to the animal's arrival in the city.
'Of the ₹5 lakh, we have already paid ₹1 lakh as an advance to the elephant's owner. While the owner is based in Delhi, the elephant would have to be brought from Jaipur. The Forest Department has pointed out that the distance to Hyderabad is too great. We are now considering arranging for an elephant from a location closer to Hyderabad, such as Karnataka. Since an elephant is required for Bonalu as well Minister Ponnam Prabhakar is already cognisant of the matter. The issue will be resolved soon,' said TGSWB Chairman Syed Azmatullah Husseni.
Sources noted that except during the COVID-19 pandemic, when lockdown restrictions were in place, the government, over the years, had consistently arranged for an elephant for both Muharram and Bonalu. They expressed confidence that a solution would be found this year as well. The sources also said that both of the Nizam's panels are on board with the current arrangements.
Meanwhile, Mir Abbas Ali Moosvi of the Anjuman-e-Tahafuz-e-Huqooq-e-Mutawalliyan Mujawareen wa Khadimeen-e-Mauroosi Ashoorkhanajaat, an association of managers of ashoorkhanas, urged the government to provide cash grants to these places of worship ahead of Muharram.
Mr Moosvi pointed out that while the Badshahi Ashoorkhana, a structure that predates the Charminar, and for which he serves as mutawalli, received ₹30,000 in aid, other ashoorkhanas in the city and across the districts — around 700 in total — are in dire need of financial support. He submitted a representation to Minister Ponnam Prabhakar seeking assistance for this purpose.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
US Senate confirms Trump nominee Susan Monarez as CDC director
Washington: The U.S. Senate voted on Tuesday night 51-47 along party lines to confirm President Donald Trump's nominee, Susan Monarez , as director of the Centers for Disease Control and Prevention, charged with leading the response to threats against public health. Monarez, a career public health official who served as acting director of the CDC until her nomination, will report to Secretary of Health and Human Services Robert F. Kennedy Jr. , who has long questioned the safety of vaccines, contrary to scientific evidence, including suggesting a link between them and autism. The first CDC director to require Senate confirmation following amendments to the Public Health Service Act, Monarez sought to distance herself somewhat from some of Kennedy's views during her confirmation hearing last month, while also praising his leadership on multiple occasions. She told a Senate committee last month that she had not seen evidence linking vaccines and autism, and promised to prioritize vaccine availability if confirmed. Monarez, the first CDC director without a medical degree since 1953, holds a PhD from the University of Wisconsin-Madison. Her research focused on developing technologies to diagnose, treat and prevent infectious diseases. She is the Trump administration's second nominee for the role. In March, the president withdrew his nomination of former Republican congressman and vaccine critic Dave Weldon, a Kennedy ally, just hours before his scheduled confirmation hearing. The United States is facing a growing measles outbreak, with confirmed cases this month reaching the highest level since the disease was declared eliminated from the country in 2000. Monarez is expected to lead the response to the outbreak, and play a critical role in tackling the spread of bird flu. Monarez will lead a diminished agency, with the White House seeking to cut the CDC's budget by almost $3.6 billion, leaving it with a $4 billion budget, and Kennedy enacting a layoff plan that cut 2,400 employees, though some 700 were rehired. Kennedy has also made major decisions on vaccines in the absence of a CDC director. It is unclear if he will continue to do so. He fired all members of the CDC's vaccine expert panel, which recommends how vaccines are used and by whom, last month, and replaced them with hand-picked advisers including anti-vaccine activists. Kennedy also announced in May that the U.S. would stop recommending routine COVID vaccinations for pregnant women and healthy children, bypassing the CDC's traditional process.
India Today
3 hours ago
- India Today
Top US vaccine official Vinay Prasad leaves agency 3 months after being appointed
The US Food and Drug Administration's (FDA) top vaccine official, Vinay Prasad, has left the agency after just three months as Director of the Centre for Biologics Evaluation and Research, a government spokesperson an oncologist who was a fierce critic of the US COVID-19 vaccine and mask mandates, was appointed in May by FDA Commissioner Marty Makary. Together they promised to speed regulatory action and pilot new review recent days, criticism of Prasad's tenure has intensified around the agency's handling of a gene therapy for Duchenne muscular dystrophy from Sarepta Therapeutics. The FDA-approved therapy played a role in the death of two teens who had advanced disease, and after a third death in a separate experimental gene therapy from the company, the FDA on July 18 asked Sarepta to stop all shipments of the approved DMD therapy, saying it had safety Loomer, a far-right activist and President Donald Trump ally, on July 20 posted a blog in which she called Prasad a "progressive leftist saboteur" who was undermining the agency's work. Loomer's critiques earlier this year led to the ouster of national security Monday, the Wall Street Journal's opinion section ran two pieces criticising Prasad, one of which called him a Bernie Sanders acolyte in MAHA drag, referring to the Trump administration's "Make America Healthy Again" movement. Both said he was not basing regulatory decisions on whether drugs helped patients, but on price."When he saw some of these sort of smear pieces, he didn't want to be a distraction," Makary said of Prasad's departure in an interview with CNBC on Tidmarsh, a former pharmaceutical executive who was recently appointed to lead the FDA's Center for Drug Evaluation and Research (CBER), will also be the acting CBER director, according to the agency's Department of Health and Human Services, which oversees the FDA, did not announce when the role would be permanently whose departure was announced late on Tuesday, did not immediately respond to a request for FDA on Monday changed course on Sarepta and said shipments to the main group of patients for the drug could changes under Prasad, who was also the agency's chief medical and science officer, included a new policy limiting the approval of COVID-19 vaccines, and his FDA division also rejected therapies from Replimmune and Capricor of Replimmune nearly doubled in value, while those of Sarepta and Capricor gained 11% and 18%, respectively, on and STAT news first reported Prasad's was a physician who joined the agency from the University of California, San Francisco. He has had stints at the National Cancer Institute and the National Institutes of FDA and other health agencies have seen multiple shakeups in recent months, under the leadership of US Health Secretary Robert F. Kennedy predecessor and long-time vaccine official at the FDA, Peter Marks, was ousted earlier this year, followed by gene therapy head Nicole Verdun."While another vacancy and another potential new face add uncertainty, we still think Prasad's departure is a net positive for the sector as many of our conversations have been overwhelmingly focused on regulatory risk and what he may or may not do," said Leerink analyst Joseph Schwartz.- EndsMust Watch IN THIS STORY#Donald Trump#White House#Covid-19
India Today
13 hours ago
- India Today
Khaleda Zia set to contest general election, confirms party leader
Khaleda Zia, the chairperson of the Bangladesh Nationalist Party (BNP) and former premier, will contest the upcoming general election, her party leader said on Vice Chairman Abdul Awal Mintoo said the 79-year-old party chief is doing well and she will contest the election, the Daily Star newspaper reported."She will be elected from Feni because she is now in good health," Mintoo told reporters after a views-exchange meeting organised by the Feni district On his discussions with Zia's son and acting BNP chairman Tarique Rahman, who is in London, Mintoo said that they believe the election will be held in the first week of February."I think, considering the current situation of the country, the election may be held even before February. Because there is a pending case in the Supreme Court regarding the caretaker government. If a caretaker government is introduced, the election must be held within 90 days," he was quoted as saying by the returned to Dhaka from London in May after four months of medical treatment. She went to London in January for advanced medical care and was admitted to The London has long suffered from liver cirrhosis, kidney disease, heart problems, diabetes, and BNP chairperson was lodged in the Old Dhaka Central Jail on February 8, 2018, after the Dhaka court sentenced her in the Zia Orphanage Trust corruption the COVID-19 outbreak, the then-Sheikh Hasina-led Awami League government temporarily released Zia from jail after 776 days through an executive order, suspending her sentence on March 25, 2020, with conditions that she would stay in her house and not leave the August 6 last year, after the ouster of the Hasina regime, Zia was freed by an order of President Mohammed March, Bangladesh's Supreme Court upheld a High Court ruling that acquitted Zia in a corruption case in which she was sentenced to seven years in jail by a lower now stands acquitted in both the Zia Orphanage Trust and Zia Charitable Trust cases, in which she had previously been convicted and served as the prime minister of Bangladesh from March 1991 to March 1996, and again from June 2001 to October 2006.- Ends
